Lancet and Pen Needles Market Research Report, By
Therapy (Insulin, (GLP-1), Growth Hormones), Gauge (17/18G, 21G, 23G), Needle
Length (4mm, 8mm, 12mm), And End Users (Medical Institutions & Research
Organizations) – The Asia Pacific Forecast till 2023
Lancet and Pen Needles Market Highlights
The Asia Pacific lancet and pen needles market size is
expected to grow at a CAGR of 6.5% during the forecast period. Lancet and pen
needles are extensively utilized for the monitoring, diagnosis, and medication
of several diseases such as diabetes and osteoporosis. The increasing prevalence
of diabetes and osteoporosis within the Asia Pacific region majorly drives the
market growth. In 2016, a study was conducted by the American Diabetes
Association, which stated that about 80% of the diabetic patients resides in
the developing countries. It was also estimated that the rise of type 2
diabetes in South Asia may grow by over 150% from 2000 to 2035.
Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/630
Moreover, in the Western Pacific region, the number of
diabetic patients is expected to rise to 201.8 million by 2035. Additionally,
according to the International Osteoporosis Foundation by 2050, over ~50% of
all osteoporotic hip fractures are projected occur in Asia. Additionally,
increasing geriatric population and growing healthcare expenditure along with
favorable government policies may boost the market growth during the forecast
period. However, the need to remove the
pin after a single use and the high cost as compared to the insulin vials may
restrain the market growth during the forecast period.
Lancet and Pen Needles Market Regional Analysis
On the regional basis the Asia
Pacific lancet and pen needles market in Asia Pacific is segmented
into Japan, India, China, the republic of Korea, Australia and the Rest of Asia
Pacific.
Japan holds a major share of the market followed by the
republic of Korea and Australia owing to well-developed healthcare sector and
high per capita healthcare expenditure. Moreover, growing geriatric population
boosts the market growth during the forecast period.
China and India has a growing market due to huge population
base, rapidly changing economy, increasing healthcare expenditure, and rising
number of pharmaceutical & biotechnological companies.
According to the Indian Brand Equity Foundation in 2017, the
Indian healthcare sector is estimated to be one of the fastest growing region
and is expected to grow at a CAGR of 22.87% and reach USD280 billion by 2020.
Moreover, increasing number of healthcare organizations like hospital, private
research institute has led the market growth in India. Rest of Asia Pacific
holds the least share of the market.
Lancet and Pen Needles Market Segmentation
The Asia Pacific lancet and pen needles market is segmented on
the basis of therapy, gauge, needle length, and end users.
On the basis of the therapy, the market is segmented into
insulin, glucagon-like peptide-1 (GLP-1), growth hormones, and others.
On the basis of the gauge, the market is categorized into
17/18G, 21G, 23G, and others.
On the basis of the needle length, the market is segmented
into 4mm, 8mm, 12mm, and others.
On the basis of end users, the market is segmented into
hospitals & clinics, medical institutions & research organizations, and
others.
Lancet and Pen Needles Market Key Players
Some of the key players in the Asia Pacific lancet and pen
needles market are BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B.
Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia
Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe), and others.
Browse Detailed TOC with COVID-19 Impact Analysis
at: https://www.marketresearchfuture.com/reports/asia-pacific-lancet-pen-needels-market-630
Browse More Related Research Reports at:
Poultry
Vaccines Market Size, Trends | Growth Analysis, 2023
RF
Microneedling market Research Report - Forecast to 2023 | MRFR
About Market Research
Future:
At Market Research Future (MRFR),
we enable our customers to unravel the complexity of various industries through
our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment